Last update 20 Mar 2025

Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Conjugated vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesNervous System DiseasesOtorhinolaryngologic Diseases+ [3]
Active Indication
ArthritisCellulitisEpiglottitis+ [3]
Inactive Indication-
Originator Organization
Changchun Heber Biological Technology Co. Ltd.
Active Organization
Changchun Heber Biological Technology Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)
CTR20210935
/ RecruitingPhase 3
合成b型流感嗜血杆菌结合疫苗III期临床研究
[Translation] Phase III clinical study of synthetic Haemophilus influenzae type b conjugate vaccine
CTR20192500
/ Active, not recruitingPhase 1
合成b型流感嗜血杆菌结合疫苗I期临床研究
[Translation] Phase I clinical study of synthetic Haemophilus influenzae type b conjugate vaccine
100 Clinical Results associated with Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)
Login to view more data
100 Translational Medicine associated with Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)
Login to view more data
100 Patents (Medical) associated with Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)
Login to view more data
100 Deals associated with Synthetic Haemophilus Influenzae Type b Conjugate Vaccine ( Changchun Heber Biological Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ArthritisPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
CellulitisPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
EpiglottitisPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
Haemophilus InfectionsPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
MeningitisPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
PneumoniaPhase 3
China
Changchun Heber Biological Technology Co. Ltd.
15 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free